TGFΒ-induced Transcription in Cancer

Overview

Journal Semin Cancer Biol

Specialty Oncology

Date 2016 Sep 3

PMID 27586372

Citations 55

Authors

Gaia Cantelli

Eva Crosas-Molist

Mirella Georgouli

Victoria Sanz-Moreno

Affiliations

Soon will be listed here.

Abstract

The Transforming Growth Factor-beta (TGFβ) pathway mediates a broad spectrum of cellular processes and is involved in several diseases, including cancer. TGFβ has a dual role in tumours, acting as a tumour suppressor in the early phase of tumorigenesis and as a tumour promoter in more advanced stages. In this review, we discuss the effects of TGFβ-driven transcription on all stages of tumour progression, with special focus on lung cancer. Since some TGFβ target genes are specifically involved in promoting metastasis, we speculate that these genes might be good targets to block tumour progression without compromising the tumour suppressor effects of the TGFβ pathway.

Citing Articles

Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms.

Orrapin S, Moonmuang S, Udomruk S, Yongpitakwattana P, Pruksakorn D, Chaiyawat P Front Immunol. 2024; 15:1394284.

PMID: 39359731 PMC: 11444963. DOI: 10.3389/fimmu.2024.1394284.

Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma.

Britton W, Cioffi I, Stonebraker C, Spence M, Okolo O, Martin C Cancers (Basel). 2024; 16(17).

PMID: 39272905 PMC: 11394608. DOI: 10.3390/cancers16173047.

Sarcomatoid carcinoma of the pancreas (Review).

Ma Y, Yang Y, Zhang H, Mugaanyi J, Hu Y, Wu S Oncol Lett. 2024; 28(4):477.

PMID: 39161336 PMC: 11332573. DOI: 10.3892/ol.2024.14610.

Renal cancer: signaling pathways and advances in targeted therapies.

Jiang A, Li J, He Z, Liu Y, Qiao K, Fang Y MedComm (2020). 2024; 5(8):e676.

PMID: 39092291 PMC: 11292401. DOI: 10.1002/mco2.676.

TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.

Mohamed F, Dewidar B, Lin T, Ebert M, Dooley S, Meindl-Beinker N Int J Exp Pathol. 2024; 105(2):64-74.

PMID: 38328944 PMC: 10951419. DOI: 10.1111/iep.12501.

References

Murphy K, Reiner S . The lineage decisions of helper T cells. Nat Rev Immunol. 2002; 2(12):933-44. DOI: 10.1038/nri954. View

Cantelli G, Orgaz J, Rodriguez-Hernandez I, Karagiannis P, Maiques O, Matias-Guiu X . TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination. Curr Biol. 2015; 25(22):2899-914. PMC: 4651903. DOI: 10.1016/j.cub.2015.09.054. View

Salvo E, Garasa S, Dotor J, Morales X, Pelaez R, Altevogt P . Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer. Mol Cancer. 2014; 13:112. PMC: 4049383. DOI: 10.1186/1476-4598-13-112. View

Leblanc R, Peyruchaud O . Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016; 128(1):24-31. DOI: 10.1182/blood-2016-01-636399. View

Wahl S, Hunt D, Wakefield L, McCartney-Francis N, Wahl L, Roberts A . Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987; 84(16):5788-92. PMC: 298948. DOI: 10.1073/pnas.84.16.5788. View

Seystahl K, Tritschler I, Szabo E, Tabatabai G, Weller M . Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro Oncol. 2014; 17(2):254-65. PMC: 4288525. DOI: 10.1093/neuonc/nou218. View

Letterio J . TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene. 2005; 24(37):5701-12. DOI: 10.1038/sj.onc.1208922. View

Foletta V, Lim M, Soosairajah J, Kelly A, Stanley E, Shannon M . Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol. 2003; 162(6):1089-98. PMC: 2172847. DOI: 10.1083/jcb.200212060. View

Shiota M, Zardan A, Takeuchi A, Kumano M, Beraldi E, Naito S . Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Res. 2012; 72(20):5261-72. DOI: 10.1158/0008-5472.CAN-12-0254. View

10.

Albrengues J, Bertero T, Grasset E, Bonan S, Maiel M, Bourget I . Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat Commun. 2015; 6:10204. PMC: 4682161. DOI: 10.1038/ncomms10204. View

11.

Roth P, Silginer M, Goodman S, Hasenbach K, Thies S, Maurer G . Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain. 2013; 136(Pt 2):564-76. DOI: 10.1093/brain/aws351. View

12.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

13.

Lee J, Lee K, Kim D, Heo D . Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol. 2004; 172(12):7335-40. DOI: 10.4049/jimmunol.172.12.7335. View

14.

Giaccone G, Bazhenova L, Nemunaitis J, Tan M, Juhasz E, Ramlau R . A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. Eur J Cancer. 2015; 51(16):2321-9. DOI: 10.1016/j.ejca.2015.07.035. View

15.

Hansen A, Arnold S, Jiang M, Palmer T, Ketova T, Merkel A . ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 2014; 74(5):1404-15. PMC: 4149913. DOI: 10.1158/0008-5472.CAN-13-1296. View

16.

Lee I, Sohn M, Lim H, Yoon S, Oh H, Shin S . Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene. 2014; 33(38):4675-84. PMC: 4180639. DOI: 10.1038/onc.2014.69. View

17.

Kulkarni A, Thyagarajan T, Letterio J . Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med. 2002; 2(3):303-27. DOI: 10.2174/1566524024605699. View

18.

Ozdamar B, Bose R, Barrios-Rodiles M, Wang H, Zhang Y, Wrana J . Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science. 2005; 307(5715):1603-9. DOI: 10.1126/science.1105718. View

19.

Koeck S, Amann A, Huber J, Gamerith G, Hilbe W, Zwierzina H . The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines. Oncol Lett. 2016; 11(4):2946-2952. PMC: 4812542. DOI: 10.3892/ol.2016.4323. View

20.

Moses H, Yang E, Pietenpol J . TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 1990; 63(2):245-7. DOI: 10.1016/0092-8674(90)90155-8. View